Trusted answers,
not just results

Integrated testing to identify the underlying cause and risk for disease progression

Impacting more than 1.5 billion people globally, chronic liver disease is a major concern for health care providers. With metabolic, viral, genetic, autoimmune, and malignant causes, liver disease affects individuals of all ages and with varied medical histories. Mayo Clinic Laboratories’ comprehensive liver disease testing menu was developed in collaboration with clinical experts and spans the array of liver disorders. Delivering end-to-end testing in one laboratory location, our evaluations provide clinicians with results that identify underlying causes and guide disease management.

The full spectrum of liver disease testing

Nonalcoholic Steatohepatitis (NASH)-FibroTest

Nikola Baumann, Ph.D., gives an overview of the new NASH-FibroTest available through Mayo Clinic Laboratories. She discusses when this testing should be ordered, how this testing improves upon previous testing approaches, and what clinical action can be taken due to the results of this testing.

The stages of liver damage

Learn more about how to order these evaluations at your institution.


  1. Moon AM, Singal AG, Tapper EB. Contemporary epidemiology of chronic liver disease and cirrhosis. Clin Gastroenterol Hepatol 2020;18:2650-2666.